# Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement Surgery

> **NCT00967447** · — · TERMINATED · sponsor: **Boehringer Ingelheim** · enrollment: 2 (actual)

## Conditions studied

- Thromboembolism
- Arthroplasty, Replacement, Hip

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00967447
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2009-02-01
- **Primary completion:** 2010-01-01
- **Final completion:** —
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00967447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00967447, "Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement Surgery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00967447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*